SOPHION BIOSCIENCE A/S: Financial statements 2023
CVR: 10021065
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 112,805 and a net result of DKK 28,022,000 compared with DKK 44,369,000 the year before. That is a decrease of 99.9% compared with the year before. Equity in the 2023 report amounted to DKK 156,953,000. The solvency ratio was 77.8%. The company had 57 employees in the financial year.
- Gross Profit
- DKK 112,805
- Profit/Loss
- DKK 28,022,000
- Equity
- DKK 156,953,000
- Total Assets
- DKK 201,723,000
- Employees
- 57
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 113 t. | 28 mio. | 157 mio. | 57 |
| 2022 | - | 117.7 mio. | 44.4 mio. | 188.1 mio. | 48 |
| 2021 | - | 98.3 mio. | 36.3 mio. | 143.8 mio. | 41 |
| 2020 | - | 77.5 mio. | 25.2 mio. | 106.5 mio. | 35 |
| 2019 | - | 78.4 mio. | 22.6 mio. | 101.1 mio. | 38 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
SOPHION BIOSCIENCE A/S has published its annual report for 2022. Gross profit came to DKK 117,686,000, and the net result was DKK 44,369,000.
About SOPHION BIOSCIENCE A/S
SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named IONS A/S and KR 228 A/S. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by Sapphire Bioscience Holding ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity in the 2025 report amounted to DKK 178,418,000.